drug
CAP-100
Phase 1updated 3mo agoby Catapult Therapeutics BV
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying CAP-100
- phase3A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
- phase2Open-label Extension of the HOPE-2 Trial
- phase1CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
- phase2A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
- phase2Intravenous Infusion of CAP-1002 in Patients With COVID-19
- phase2HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)
- phase2Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)
- phase2Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that